Junevity develops siRNA therapeutics to reset cell health.
Total raised: $10M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.02.2025 | Seed | $10M | - |
Mentions in press and media 4
| Date | Title | Description |
| 01.03.2025 | Junevity: Pioneering the Future of Longevity with $10 Million Seed Funding | In the bustling heart of San Francisco, a biotechnology company named Junevity is making waves. With a mission to extend both lifespan and healthspan, Junevity has successfully raised $10 million in seed funding. This financial boost, led b... |
| 27.02.2025 | Junevity: $10 Million (Seed) Raised For Developing Cell Reset Therapeutics For Longevity | Junevity – a biotechnology company on a mission to extend lifespan and healthspan by resetting cell damage from age-related diseases – announced $10 million in seed funding led by Goldcrest Capital and Godfrey Capital. Junevity’s RESET plat... |
| 13.02.2025 | Junevity Raises $10M in Seed Funding | Junevity, a San Francisco, CA-based biotechnology cell reset therapeutics company, raised $10M in seed funding. The round was led by Goldcrest Capital and Godfrey Capital. The company intends to use the funds to expand operations and its R&... |
| - | Junevity | “Junevity develops siRNA therapeutics to reset cell health.” |